Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004644275 | SCV005133486 | uncertain significance | Inborn genetic diseases | 2024-04-08 | criteria provided, single submitter | clinical testing | The c.1912T>G (p.C638G) alteration is located in exon 14 (coding exon 14) of the KMT2C gene. This alteration results from a T to G substitution at nucleotide position 1912, causing the cysteine (C) at amino acid position 638 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |